- Home
- SAFE vs OCUL Comparison
SAFE vs OCUL Comparison
Compare SAFE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFE
- OCUL
- Stock Information
- Founded
- SAFE 2016
- OCUL 2006
- Country
- SAFE United States
- OCUL United States
- Employees
- SAFE N/A
- OCUL N/A
- Industry
- SAFE Real Estate Investment Trusts
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- SAFE Real Estate
- OCUL Health Care
- Exchange
- SAFE Nasdaq
- OCUL Nasdaq
- Market Cap
- SAFE 1.4B
- OCUL 1.4B
- IPO Year
- SAFE 2017
- OCUL 2014
- Fundamental
- Price
- SAFE $20.22
- OCUL $9.16
- Analyst Decision
- SAFE Buy
- OCUL Strong Buy
- Analyst Count
- SAFE 9
- OCUL 8
- Target Price
- SAFE $28.44
- OCUL $16.50
- AVG Volume (30 Days)
- SAFE 397.1K
- OCUL 889.3K
- Earning Date
- SAFE 10-28-2024
- OCUL 11-14-2024
- Dividend Yield
- SAFE 3.50%
- OCUL N/A
- EPS Growth
- SAFE N/A
- OCUL N/A
- EPS
- SAFE 1.70
- OCUL N/A
- Revenue
- SAFE $401,069,000.00
- OCUL $61,442,000.00
- Revenue This Year
- SAFE N/A
- OCUL $15.49
- Revenue Next Year
- SAFE $6.18
- OCUL $13.31
- P/E Ratio
- SAFE $11.93
- OCUL N/A
- Revenue Growth
- SAFE 23.33
- OCUL 6.45
- 52 Week Low
- SAFE $17.91
- OCUL $2.05
- 52 Week High
- SAFE $28.80
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- SAFE 29.26
- OCUL 34.86
- Support Level
- SAFE $20.09
- OCUL $10.46
- Resistance Level
- SAFE $21.58
- OCUL $11.12
- Average True Range (ATR)
- SAFE 0.75
- OCUL 0.57
- MACD
- SAFE -0.04
- OCUL -0.22
- Stochastic Oscillator
- SAFE 5.40
- OCUL 0.60
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that is net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.